ConductScience.org, home

Paper6202963

Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.

Leonetti G and 5 others. J Cardiovasc Pharmacol, 1984. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients. Papers, record 6202963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6202963

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.
PubMed
Journal
J Cardiovasc Pharmacol
PubMed
Year
1984
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
2.54
iCite
Revised in PubMed
2013-11-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leonetti GG
2Gradnik RR
3Terzoli LL
4Fruscio MM
5Rupoli LL
6Zanchetti AA

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
Blood PressureMajor topic
Heart RateMajor topic
HypertensionMajor topic
NifedipineMajor topic
Aldosterone
Felodipine
Female
Humans
Kidney Function Tests
Male
Middle Aged
Renin
Sodium

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
7827397Do calcium channel blockers have renal protective effects?Drugs Aging1994https://conductscience.org/library/papers/7827397PubMed
3987547Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients.Drugs1985https://conductscience.org/library/papers/3987547PubMed
3987541Haemodynamic effects of intravenous felodipine in normotensive and hypertensive subjects.Drugs1985https://conductscience.org/library/papers/3987541PubMed
3443065Renal effects of felodipine in hypertension.Drugs1987https://conductscience.org/library/papers/3443065PubMed
3327680Felodipine monotherapy in systolic hypertension in the elderly.Drugs1987https://conductscience.org/library/papers/3327680PubMed
3327679Short and long term treatment of essential hypertension with felodipine as monotherapy.Drugs1987https://conductscience.org/library/papers/3327679PubMed
3319491'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.Drugs1987https://conductscience.org/library/papers/3319491PubMed
3154319Hemodynamic effects of felodipine in congestive heart failure.Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/3154319PubMed
3107605Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3107605PubMed
3069435Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.Drugs1988https://conductscience.org/library/papers/3069435PubMed
2993927Studies on the effects of felodipine on the vascular resistance and reactivity in pentobarbital anesthetized dogs.Naunyn Schmiedebergs Arch Pharmacol1985https://conductscience.org/library/papers/2993927PubMed
2985351Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers.Drugs1985https://conductscience.org/library/papers/2985351PubMed
2905154Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.Br J Clin Pharmacol1988https://conductscience.org/library/papers/2905154PubMed
2487551Felodipine in severe chronic congestive heart failure: acute effects on central hemodynamics and regional blood flow distribution.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2487551PubMed
2278868Effects of calcium antagonists on the hypertensive kidney.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2278868PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6202963

GET https://conductscience.org/api/papers/v1/6202963/authors